Pharmaceutical Supply – Oral Contraceptive Tablets

The contract involves the supply of FDA-approved generic oral contraceptive tablets containing Norgestrel and Ethinyl Estradiol, precisely aligned with the National Stock Number 6505011479542 and all applicable Defense Logistics Agency medical procurement standards. These tablets must comply with stringent quality, safety, and manufacturing specifications required for federal medical use, ensuring consistent efficacy and reliability for distribution through military and defense healthcare channels. The product is subject to rigorous regulatory oversight and must meet all current Good Manufacturing Practices as defined by the FDA and DLA. The contract is categorized as a subcontract under NAICS code 325412, which pertains to pharmaceutical and botanical product manufacturing, with the Defense Logistics Agency acting as the procuring entity under the Department of Defense. The solicitation was posted on July 14, 2026, and the performance and delivery are expected to conform to DLA’s logistical and supply chain requirements, though specific delivery locations and points of contact are not detailed. The contract reference is linked through the DIBBS system, indicating formal award and tracking under the contract numbers SPE2DX25D9900 and SPE2DP26F7629 with a line item count of 7121.